Recruiting studies: Middle And Low Rectal Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Node-sparing Radiotherapy Combined With Total Neoadjuvant CAPOX and Sintilimab for MSS Middle and Low Rectal Cancer
Phase 2 · 1 location(s) · Jinhua Central Hospital · NCT06204094 A Single-center, Phase II Study on Efficacy & Safety of SCRT+CAPOX+Serplulimab+Bevacizumab for MSS Rectal Cancer
Phase 2 · 1 location(s) · First Affiliated Hospital of Wenzhou Medical University · NCT07347951 REsults of LOw Anterior Resections With or Without Preventive Stoma in Nonemergency Department
NA · 7 location(s) · ANO Scientific and Practical Club for the Development of Mod · NCT07463261 Neoadjuvant Long-course Chemoradiation Plus PD-1 Blockade for Mid-low Locally Advanced Rectal Cancer
Phase 2 · 8 location(s) · Beijing Friendship Hospital · NCT05245474 Node-Sparing Short-Course Radiotherapy Sequential Chemotherapy and PD-1 Inhibitor for Mid/Low pMMR/MSS Rectal Cancer (MO
Phase 2/Phase 3 · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT06958432 Standard Dose Versus High Dose of Radiotherapy in Rectal Preservation With Chemo-radiotherapy in Rectal Cancer Patients
Phase 3 · 5 location(s) · Vejle Hospital · NCT04095299 Nodes-sparing Short-course Radiation Combined With CAPOX and Tislelizumab for MSS Middle and Low Rectal Cancer
Phase 2 · 1 location(s) · Sir Run Run Shaw Hospital · NCT05972655 Intraoperative Rectal Lavage to Prevent Local Recurrence After Laparoscopic Mid-to-Low Rectal Cancer Resection: A Multic
NA · 1 location(s) · Sun Yat-sen University · NCT07512232 Somatostatin Plus Clear Liquid Diet Versus Diverting Stoma in Patients With Rectal Cancer Undergoing Ultra-Low Anterior
NA · 3 location(s) · Tongji Hospital · NCT07605611 Safety of Mid and Low Rectal Cancer Surgery Without Dissection of the No.253 Lymph Node (S-M-O-O-T-H)
NA · 8 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06146946 Neoadjuvant Chemoradiotherapy Plus Tislelizumab With or Without Probio-M9 in pMMR/MSS Locally Advanced Rectal Cancer
Phase 2 · 1 location(s) · Seventh Medical Center of PLA General Hospital · NCT07458529 Modified Long-Course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for MSS/pMMR High-risk Mid/Low LARC (MODIF
Phase 2 · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT06923345 Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Wit
Phase 2/Phase 3 · 1 location(s) · The First Hospital of Jilin University · NCT07505472 Node-Sparing Short-Course Radiation Combined With Capecitabine and PD-1/CTLA-4 for MSS Early Rectal Cancer
Phase 2 · 1 location(s) · Sir Run Run Shaw Hospital · NCT07068763 Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer
NA · 16 location(s) · Sun Yat-sen University · NCT02966483

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.